A platform for monitoring symptoms in frontotemporal degeneration syndromes
Official title: A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration Syndromes
Funded at Biosensics, LLC · NIH-10707379 · Data updated 2026-11-12
This study is looking for people with Progressive Supranuclear Palsy (PSP) to help test a new system that uses wearable devices to keep track of their movement, speech, and thinking over a year, with the hope of improving care and quality of life for those with this condition.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Biosensics, LLC NIH-funded |
| Lab location | 1 site (Newton, UNITED STATES) |
| Project start | September 30, 2022 |
| Project end | August 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $1,246,364 |
| NIH project number | 5R44AG080861-02 |
| Project ID | NIH-10707379 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Progressive Supranuclear Palsy (PSP) or other frontotemporal lobar degeneration syndromes.
✕Less likely to help
Patients with other forms of dementia or neurodegenerative disorders that do not fall under the FTLD spectrum may not benefit from this research.
What this research studies
This research focuses on developing a comprehensive platform that uses wearable sensors and digital tests to remotely monitor motor symptoms, speech, and cognitive functions in patients with frontotemporal lobar degeneration (FTLD) syndromes, particularly Progressive Supranuclear Palsy (PSP). Over a 12-month period, 60 participants will be monitored to collect valuable data that can help in understanding the progression of these conditions. The goal is to create a validated solution that can be used for ongoing monitoring and potentially improve patient care. This innovative approach aims to enhance the quality of life for patients by providing real-time insights into their health status.
Why it matters
Potential benefit: If successful, this research could lead to improved monitoring and management of symptoms in patients with FTLD syndromes, enhancing their quality of life.
How similar studies have gone: Previous research has shown promise in using wearable technology for monitoring neurodegenerative conditions, indicating that this approach could be effective.
Where this research is happening
-
Biosensics, LLC
Newton, United States Active
Researchers
- Principal investigator: Vaziri, Ashkan — Biosensics, LLC
- Study coordinator: Vaziri, Ashkan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.